rs544956641
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000187.4(HGD):c.365C>T(p.Ala122Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A122D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000187.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HGD | ENST00000283871.10 | c.365C>T | p.Ala122Val | missense_variant | 6/14 | 1 | NM_000187.4 | ENSP00000283871.5 | ||
HGD | ENST00000476082.2 | c.242C>T | p.Ala81Val | missense_variant | 5/7 | 5 | ENSP00000419560.2 | |||
HGD | ENST00000485313.5 | n.473C>T | non_coding_transcript_exon_variant | 7/7 | 5 | |||||
HGD | ENST00000492108.5 | n.-5C>T | upstream_gene_variant | 2 | ENSP00000419838.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251388Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135862
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461590Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727128
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74482
ClinVar
Submissions by phenotype
Alkaptonuria Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Lifecell International Pvt. Ltd | - | A Homozygote Missense variant c.365C>T in Exon 6 of the HGD gene that results in the amino acid substitution p.Ala122Val was identified. The observed variant has a maximum allele frequency of 0.00006/--% in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. This variant has been reported as Pathogenic/Likely Pathogenic in the ClinVar database (Variant ID: 418295). This variant was reported among the patients for Alkaptonuria (Vilboux et al., 2009). Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines. - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The observed missense c.365C>T (p.Ala122Val) variant in HGD gene has been previously reported in homozygous and compound heterozygous state in multiple individuals affected with Alkaptonuria (Khalil R et al. 2021; Danda S et al. 2020). The variant was segregated with the disease in affected family members. Experimental evidence suggests that this variant has 58% residual activity compared to the wild type indicating moderately tolerable variant (Lequeue S, et al., 2022). This variant shows a founder effect in Jordanian patients and is located in a mutational hot spot. Another missense variant p.Ala122Asp has been reported at the same position (Sen Gupta PS, et al., 2021). The p.Ala122Val variant is present with allele frequency of 0.005% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Likely Pathogenic/ Pathogenic (multiple submitters). Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Tolerated and MutationTaster - Disease causing/) predicts conflicting evidence on protein structure and function for this variant. The reference amino acid at this position on HGD gene is predicted as conserved by GERP++ and PhyloP across 100 vertebrates.The amino acid Ala at position 122 is changed to a Val changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 122 of the HGD protein (p.Ala122Val). This variant is present in population databases (rs544956641, gnomAD 0.04%). This missense change has been observed in individual(s) with alkaptonuria (PMID: 12501223, 19862842, 23430897, 25804398). ClinVar contains an entry for this variant (Variation ID: 188865). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HGD protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 07, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Jul 03, 2014 | - - |
Pathogenic, no assertion criteria provided | research | Department Of Human Genetics, Institute Of Clinical And Translational Research, Biomedical Research Center, Slovak Academy Of Sciences | - | The variant was originally described in AKU patient in PMID:12501223. It has been submitted to the HGD gene mutation database (http://hgddatabase.cvtisr.sk/, DB-ID: AKU_00031). - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 03, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at